Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
Open accessThe DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Abstract
Nanotechnology has brought a variety of new possibilities into biological discovery and clinical practice. In particular, nano-scaled carriers have revolutionalized drug delivery, allowing for therapeutic agents to be selectively targeted on an organ, tissue and cell specific level, also minimizing exposure of healthy tissue to drugs. In this review we discuss and analyze three issues, which are considered to be at the core of nano-scaled drug delivery systems, namely functionalization of nanocarriers, delivery to target organs and in vivo imaging. The latest developments on highly specific conjugation strategies that are used to attach biomolecules to the surface of nanoparticles (NP) are first reviewed. Besides drug carrying capabilities, the functionalization of nanocarriers also facilitate their transport to primary target organs. We highlight the leading advantage of nanocarriers, i.e. their ability to cross the blood-brain barrier (BBB), a tightly packed layer of endothelial cells surrounding the brain that prevents high-molecular weight molecules from entering the brain. The BBB has several transport molecules such as growth factors, insulin and transferrin that can potentially increase the efficiency and kinetics of brain-targeting nanocarriers. Potential treatments for common neurological disorders, such as stroke, tumours and Alzheimer's, are therefore a much sought-after application of nanomedicine. Likewise any other drug delivery system, a number of parameters need to be registered once functionalized NPs are administered, for instance their efficiency in organ-selective targeting, bioaccumulation and excretion. Finally, direct in vivo imaging of nanomaterials is an exciting recent field that can provide real-time tracking of those nanocarriers. We review a range of systems suitable for in vivo imaging and monitoring of drug delivery, with an emphasis on most recently introduced molecular imaging modalities based on optical and hybrid contrast, such as fluorescent protein tomography and multispectral optoacoustic tomography. Overall, great potential is foreseen for nanocarriers in medical diagnostics, therapeutics and molecular targeting. A proposed roadmap for ongoing and future research directions is therefore discussed in detail with emphasis on the development of novel approaches for functionalization, targeting and imaging of nano-based drug delivery systems, a cutting-edge technology poised to change the ways medicine is administered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hu, Q., Chen, C., Yan, J., Yang, X., Shi, X., Zhao, J., Lei, J., Yang, L., Wang, K., Chen, L., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.007 · Cited by 96
RetractedToxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Semiconductor Nanocrystals as Fluorescent Biological Labels
Bruchez, M., Moronne, M., Gin, P., Weiss, S., & Alivisatos, A. P. (1998) · Science · doi:10.1126/science.281.5385.2013 · Cited by 8,613
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,278
Deep tissue two-photon microscopy
Helmchen, F., & Denk, W. (2005) · Nature Methods · doi:10.1038/nmeth818 · Cited by 4,153
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999) · Journal of Combinatorial Chemistry · doi:10.1021/cc9800071 · Cited by 3,068
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629 · cited 1×
“Another especial feature of BBB is the structural differences that exist between the endothelia of the brain capillaries and endothelia in other capillaries, such as tight junctions between adjacent endothelial cells [31,32], a lack of fenestrations (perforations) and a lack of pinocytotic vesicles [33-38].”
BackgroundMagnetic nanoparticles in MR imaging and drug delivery
Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,594
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M. W., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,471
Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins
Nam, J.-M., Thaxton, C. S., & Mirkin, C. A. (2003) · Science · doi:10.1126/science.1088755 · Cited by 2,390
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,364
Optical Sectioning Deep Inside Live Embryos by Selective Plane Illumination Microscopy
Huisken, J., Swoger, J., Del Bene, F., Wittbrodt, J., & Stelzer, E. H. K. (2004) · Science · doi:10.1126/science.1100035 · Cited by 2,355
Nanoparticle-Based Bio-Barcodes for the Ultrasensitive Detection of Proteins*
Nam, J.-M., Thaxton, C. S., & Mirkin, C. A. (2020) · Spherical Nucleic Acids · doi:10.1201/9781003056713-94 · Cited by 2,035
Shedding light onto live molecular targets
Weissleder, R., & Ntziachristos, V. (2003) · Nature Medicine · doi:10.1038/nm0103-123 · Cited by 1,909
Self-citationNanosilver: A nanoproduct in medical application
Chen, X., & Schluesener, H. J. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2007.10.004 · Cited by 1,888
Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging
Zhang, H. F., Maslov, K., Stoica, G., & Wang, L. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1220 · Cited by 1,854
Wang, X., Pang, Y., Ku, G., Xie, X., Stoica, G., & Wang, L. V. (2003) · Nature Biotechnology · doi:10.1038/nbt839 · Cited by 1,700
The potential risks of nanomaterials: a review carried out for ECETOC.
Borm, P. J. A., Robbins, D. J., Haubold, S., Kuhlbusch, T. A. J., Fissan, H. J., Donaldson, K., Schins, R. P. F., Stone, V., Kreyling, W. G., Lademann, J. M., et al. (2006) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-3-11 · Cited by 1,604
Self-citationIn vivo imaging of tumors with protease-activated near-infrared fluorescent probes
Weissleder, R., Tung, C.-H., Mahmood, U., & Bogdanov, A. (1999) · Nature Biotechnology · doi:10.1038/7933 · Cited by 1,591
Looking and listening to light: the evolution of whole-body photonic imaging
Ntziachristos, V., Ripoll, J., Wang, L. V., & Weissleder, R. (2005) · Nature Biotechnology · doi:10.1038/nbt1074 · Cited by 1,557
Self-citationSolid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Carbon nanotubes as photoacoustic molecular imaging agents in living mice
De La Zerda, A., Zavaleta, C., Keren, S., Vaithilingam, S., Bodapati, S., Liu, Z., Levi, J., Smith, B. R., Ma, T.-J., Oralkan, O., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.231 · Cited by 1,271
Translocation of Inhaled Ultrafine Manganese Oxide Particles to the CentralNervous System
Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., Potter, R., Maynard, A., Ito, Y., Finkelstein, J., et al. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9030 · Cited by 1,180
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · cited 1×
“PBCA NPs coated with surfactants have been successfully used in the delivery of number of drugs across the BBB [137,138], including the peptides (hexapeptide dalargin and the dipeptide kytorphin), anti-tumour antibiotic doxorubicin (DOX), loperamide, the NMDA receptor antagonist MRZ 2/576, and tubocurarine [137-142].”
MethodEndocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Weissleder, R., Elizondo, G., Wittenberg, J., Rabito, C. A., Bengele, H. H., & Josephson, L. (1990) · Radiology · doi:10.1148/radiology.175.2.2326474 · Cited by 1,028
Ntziachristos, V., Bremer, C., & Weissleder, R. (2003) · European Radiology · doi:10.1007/s00330-002-1524-x · Cited by 982
Self-citationNanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles
Rabin, O., Manuel Perez, J., Grimm, J., Wojtkiewicz, G., & Weissleder, R. (2006) · Nature Materials · doi:10.1038/nmat1571 · Cited by 942
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922 · cited 2×
“Tat, Nef, gp120 + IFN-gamma HIV-1-associated dysfunction [28-30,120,121]”
BackgroundBlood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Fluorescence molecular tomography resolves protease activity in vivo
Ntziachristos, V., Tung, C.-H., Bremer, C., & Weissleder, R. (2002) · Nature Medicine · doi:10.1038/nm729 · Cited by 827
Self-citationApolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · cited 1×
“blood after injection and thus seem to mimic lipoprotein particles that could be taken up by the brain capillary endothelial cells via receptor-mediated endocytosis [76-78].”
BackgroundNanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9195-0 · Cited by 775
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679 · cited 2×
“The total brain exposure, and thus the pharmacological efficacy of a drug or drug candidate, depends on its drug uptake which in turn depends on a combination of factors, including the physical barrier presented by the BBB and the BCSF and the affinity of the substrate for specific transport systems located at both si…”
BackgroundTranslocation and potential neurological effects of fine and ultrafine particles a critical update
Peters, A., Veronesi, B., Calderón‐Garcidueñas, L., Gehr, P., Chen, L., Geiser, M., Reed, W. R., Rothen‐Rutishauser, B., Schürch, S., & Schulz, H. (2006) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-3-13 · Cited by 675
The mighty mouse: genetically engineered mouse models in cancer drug development
Sharpless, N. E., & DePinho, R. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2110 · Cited by 661
Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo
Razansky, D., Distel, M., Vinegoni, C., Ma, R., Perrimon, N., Köster, R. W., & Ntziachristos, V. (2009) · Nature Photonics · doi:10.1038/nphoton.2009.98 · Cited by 644
Self-citationRole of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells
Molday, R. S., & Mackenzie, D. (1982) · Journal of Immunological Methods · doi:10.1016/0022-1759(82)90007-2 · Cited by 616
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592 · cited 1×
“As for nanocarriers to serve as good candidates for drug delivery across the BBB can be summarized as follows [90,28]:”
BackgroundUlbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557 · cited 5×
“The BBB has several transport molecules that can potentially increase the efficiency and kinetics of nanocarriers towards brains [103], such as, growth factors (e.g. epidermal growth factor [58], vascular endothelial growth factor [104], basic fibroblast growth factor [105], insulin-like growth factors (IGF-I and -II)…”
BackgroundInfluentialPassage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Pantarotto, D., Partidos, C. D., Hoebeke, J., Brown, F., Kramer, E., Briand, J.-P., Muller, S., Prato, M., & Bianco, A. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.011 · Cited by 538
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Biodistribution of 1.4‐ and 18‐nm Gold Particles in Rats
Semmler‐Behnke, M., Kreyling, W. G., Lipka, J., Fertsch, S., Wenk, A., Takenaka, S., Schmid, G., & Brandau, W. (2008) · Small · doi:10.1002/smll.200800922 · Cited by 501
Self-citationStoeger, T., Reinhard, C., Takenaka, S., Schroeppel, A., Karg, E., Ritter, B., Heyder, J., & Schulz, H. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8266 · Cited by 486
Self-citationNtziachristos, V., & Weissleder, R. (2001) · Optics Letters · doi:10.1364/ol.26.000893 · Cited by 475
Self-citationStrategies to advance translational research into brain barriers
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70326-5 · Cited by 474 · cited 1×
“To this end, efficient delivery of many potentially therapeutic and diagnostic compounds to specific areas of the brain is hindered by the BBB, the blood cerebrospinal fluid barrier (BCSF), or other specialized CNS barriers [16].”
BackgroundReceptor-Mediated Transport of Insulin Across Endothelial Cells
King, G. L., & Johnson, S. M. (1985) · Science · doi:10.1126/science.3883490 · Cited by 471
What do we (need to) know about the kinetic properties of nanoparticles in the body?
Hagens, W. I., Oomen, A. G., de Jong, W. H., Cassee, F. R., & Sips, A. J. A. M. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.07.006 · Cited by 464
Getting into the Brain: Approaches to Enhance Brain Drug Delivery
Patel, M. M., Goyal, B. R., Bhadada, S. V., Bhatt, J. S., & Amin, A. F. (2009) · CNS Drugs · doi:10.2165/0023210-200923010-00003 · Cited by 461
The BARC biosensor applied to the detection of biological warfare agents
Edelstein, R. L., Tamanaha, C. R., Sheehan, P. E., Miller, M. M., Baselt, D. R., Whitman, L. J., & Colton, R. J. (2000) · Biosensors and Bioelectronics · doi:10.1016/s0956-5663(99)00054-8 · Cited by 456
Wang, J., Liu, Y., Jiao, F., Lao, F., Li, W., Gu, Y., Li, Y., Ge, C., Zhou, G., Li, B., et al. (2008) · Toxicology · doi:10.1016/j.tox.2008.09.014 · Cited by 450
Structural and functional aspects of the blood-brain barrier
Begley, D. J., & Brightman, M. W. (2003) · Peptide Transport and Delivery into the Central Nervous System · doi:10.1007/978-3-0348-8049-7_2 · Cited by 445
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Jagger, C., Gillies, C., Moscone, F., Cambois, E., Van Oyen, H., Nusselder, W., & Robine, J.-M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61594-9 · Cited by 437
Lipid nanoparticles for parenteral delivery of actives
Joshi, M. D., & Müller, R. H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.003 · Cited by 433
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 424
Cytotoxicity of single-wall carbon nanotubes on human fibroblasts
Tian, F., Cui, D., Schwarz, H., Estrada, G. G., & Kobayashi, H. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.03.008 · Cited by 414
Self-citationGao, B., Hagenbuch, B., Kullak-Ublick, G. A., Benke, D., Aguzzi, A., & Meier, P. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39041-x · Cited by 412
Cell Motility and Metastatic Potential Studies Based on Quantum Dot Imaging of Phagokinetic Tracks
Parak, W. J., Boudreau, R., Le Gros, M., Gerion, D., Zanchet, D., Micheel, C. M., Williams, S. C., Alivisatos, A. P., & Larabell, C. (2002) · Advanced Materials · doi:10.1002/1521-4095(20020618)14:12<882::aid-adma882>3.0.co;2-y · Cited by 409
Ultrafine Particle–Lung Interactions: Does Size Matter?
Kreyling, W. G., Semmler-Behnke, M., & Möller, W. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.74 · Cited by 394
Self-citationInsulin-like growth factors cross the blood-brain barrier
Reinhardt, R., & Bondy, C. A. (1994) · Endocrinology · doi:10.1210/en.135.5.1753 · Cited by 391
A submillimeter resolution fluorescence molecular imaging system for small animal imaging
Graves, E. E., Ripoll, J., Weissleder, R., & Ntziachristos, V. (2003) · Medical Physics · doi:10.1118/1.1568977 · Cited by 390
Self-citationReceptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier
Fillebeen, C., Descamps, L., Dehouck, M.-P., Fenart, L., Benaı̈ssa, M., Spik, G., Cecchelli, R., & Pierce, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7011 · Cited by 385
RNA interference: From gene silencing to gene-specific therapeutics
Leung, R. K. M., & Whittaker, P. A. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.004 · Cited by 382
Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
Fischer, H., Gottschlich, R., & Seelig, A. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900434 · Cited by 371
Transporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363
Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363
Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain
Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 362
Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Ntziachristos, V., Schellenberger, E. A., Ripoll, J., Yessayan, D., Graves, E., Bogdanov, A., Josephson, L., & Weissleder, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401137101 · Cited by 348
Self-citationMolecular mechanisms involved in T cell migration across the blood–brain barrier
Engelhardt, B. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0409-y · Cited by 343
Tat Peptide as an Efficient Molecule To Translocate Gold Nanoparticles into the Cell Nucleus
de la Fuente, J. M., & Berry, C. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050033+ · Cited by 342
Self-citationBawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 337
Impaired transport of leptin across the blood-brain barrier in obesity☆
Banks, W. A., DiPalma, C. R., & Farrell, C. L. (1999) · Peptides · doi:10.1016/s0196-9781(99)00139-4 · Cited by 334
Kumagai, A. K., Eisenberg, J. B., & Pardridge, W. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48160-4 · Cited by 325
Kabanov, A. V., Batrakova, E. V., & Miller, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00176-x · Cited by 325
MRI-Guided Diffuse Optical Spectroscopy of Malignant and Benign Breast Lesions
Ntziachristos, V., Yodh, A. G., Schnall, M. D., & Chance, B. (2002) · Neoplasia · doi:10.1038/sj.neo.7900244 · Cited by 321
Self-citationTAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314
Juillerat-Jeanneret, L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.005 · Cited by 314
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
Lu, W., Zhang, Y., Tan, Y.-Z., Hu, K.-L., Jiang, X.-G., & Fu, S.-K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.027 · Cited by 311
Novel Receptor-Targeted Fluorescent Contrast Agents for In Vivo Tumor Imaging
Achilefu, S. A., Dorshow, R. B., Bugaj, J. E., & Rajagopalan, R. (2000) · Investigative Radiology · doi:10.1097/00004424-200008000-00004 · Cited by 310
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting
Wang, X., Chi, N., & Tang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.005 · Cited by 305
In Vivo Skin Penetration of Quantum Dot Nanoparticles in the Murine Model: The Effect of UVR
Mortensen, L. J., Oberdörster, G., Pentland, A. P., & DeLouise, L. A. (2008) · Nano Letters · doi:10.1021/nl801323y · Cited by 302
Petri, B., Bootz, A., Khalansky, A., Hekmatara, T., Müller, R., Uhl, R., Kreuter, J., & Gelperina, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 298
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
DATE, A., JOSHI, M., & PATRAVALE, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.009 · Cited by 293
Manohar, S., Vaartjes, S. E., van Hespen, J. C. G., Klaase, J. M., van den Engh, F. M., Steenbergen, W., & van Leeuwen, T. G. (2007) · Optics Express · doi:10.1364/oe.15.012277 · Cited by 287
WILSON, B., SAMANTA, M., SANTHI, K., KUMAR, K., PARAMAKRISHNAN, N., & SURESH, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.009 · Cited by 278
Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier
Schroeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275
Role of the pro‐inflammatory cytokines TNF‐α and IL‐1β in HIV‐associated dementia
Brabers, N. A. C. H., & Nottet, H. S. L. M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01657.x · Cited by 265
Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S., & Langer, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.012 · Cited by 262
Nanomedicine: Application of Nanobiotechnology in Medical Practice
Jain, K. K. (2008) · Medical Principles and Practice · doi:10.1159/000112961 · Cited by 247
Noninvasive Functional Imaging of Human Brain Using Light
Benaron, D. A., Hintz, S. R., Villringer, A., Boas, D., Kleinschmidt, A., Frahm, J., Hirth, C., Obrig, H., van Houten, J. C., Kermit, E. L., et al. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00005 · Cited by 239
Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle
Sosnovik, D. E., Schellenberger, E. A., Nahrendorf, M., Novikov, M. S., Matsui, T., Dai, G., Reynolds, F., Grazette, L., Rosenzweig, A., Weissleder, R., et al. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20617 · Cited by 236
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
Barriers in the brain: a renaissance?
Saunders, N. R., Ek, C. J., Habgood, M. D., & Dziegielewska, K. M. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.03.003 · Cited by 228
Lu, W., Sun, Q., Wan, J., She, Z., & Jiang, X.-G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2354 · Cited by 219
Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles
Couvreur, P., Kante, B., Grislain, L., Roland, M., & Speiser, P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710717 · Cited by 217
Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction
Chen, J., Tung, C.-H., Allport, J. R., Chen, S., Weissleder, R., & Huang, P. L. (2005) · Circulation · doi:10.1161/01.cir.0000160936.91849.9f · Cited by 213
Intracellular hyperthermia for cancer using magnetite cationic liposomes
Shinkai, M., Yanase, M., Suzuki, M., Honda, H., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (1999) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(98)00586-1 · Cited by 211
Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems
Tsuji, A. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.54 · Cited by 209
Biomimetic processing of nanocrystallite bioactive apatite coating on titanium
Ma, J., Wong, H., Kong, L. B., & Peng, K. W. (2003) · Nanotechnology · doi:10.1088/0957-4484/14/6/310 · Cited by 207
Receptor-mediated endocytosis of transferrin at the blood-brain barrier
Roberts, R. L., Fine, R. E., & Sandra, A. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.2.521 · Cited by 203
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Adibhatla, R., & Hatcher, J. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784936608 · Cited by 196
Sosnovik, D. E., Nahrendorf, M., Deliolanis, N., Novikov, M., Aikawa, E., Josephson, L., Rosenzweig, A., Weissleder, R., & Ntziachristos, V. (2007) · Circulation · doi:10.1161/circulationaha.106.663351 · Cited by 195
Self-citationMultispectral photoacoustic imaging of fluorochromes in small animals
Razansky, D., Vinegoni, C., & Ntziachristos, V. (2007) · Optics Letters · doi:10.1364/ol.32.002891 · Cited by 193
Self-citationGelperina, S. E., Khalansky, A. S., Skidan, I. N., Smirnova, Z. S., Bobruskin, A. I., Severin, S. E., Turowski, B., Zanella, F. E., & Kreuter, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00456-8 · Cited by 185
Detection and quantification of magnetically labeled cells by cellular MRI
Liu, W., & Frank, J. A. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.09.021 · Cited by 182
Liang, H.-F., Chen, C.-T., Chen, S.-C., Kulkarni, A. R., Chiu, Y.-L., Chen, M.-C., & Sung, H.-W. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.10.027 · Cited by 181
Wang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179
Liu, G., Men, P., Harris, P. L. R., Rolston, R. K., Perry, G., & Smith, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.020 · Cited by 178
shRNA and siRNA delivery to the brain
Pardridge, W. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.008 · Cited by 176 · cited 2×
“by poly ethylene glycol (PEG) attachment for siRNA delivery show significant advantage in brain targeting [98].”
BackgroundOlbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
Xie, F. Y., Woodle, M. C., & Lu, P. Y. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03668-8 · Cited by 174
BARRIER MECHANISMS IN THE BRAIN, II. IMMATURE BRAIN
Saunders, N., Habgood, M., & Dziegielewska, K. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.02987.x · Cited by 173
MacKay, J. A., Deen, D. F., & Szoka, F. C. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.007 · Cited by 172
Systemic trafficking of plant virus nanoparticles in mice via the oral route
Rae, C. S., Wei Khor, I., Wang, Q., Destito, G., Gonzalez, M. J., Singh, P., Thomas, D. M., Estrada, M. N., Powell, E., Finn, M. G., et al. (2005) · Virology · doi:10.1016/j.virol.2005.08.017 · Cited by 171
Lü, W., Tan, Y.-Z., Hu, K., & Jiang, X. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.043 · Cited by 168
Barriers in the Immature Brain
Saunders, N. R., Knott, G. W., & Dzięgielewska, K. M. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006991809927 · Cited by 163
Kim, H. R., Gil, S., Andrieux, K., Nicolas, V., Appel, M., Chacun, H., Desmaële, D., Taran, F., Georgin, D., & Couvreur, P. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6390-x · Cited by 163
Endothelial Vesicles in the Blood–Brain Barrier: Are They Related to Permeability?
Stewart, P. A. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007026504843 · Cited by 162
Molecular basis for heterogeneity in human neuroblastomas
Brodeur, G. M. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00040-p · Cited by 162
Drug Delivery Across the Blood-Brain Barrier
Chen, Y., Dalwadi, G., & Benson, H. (2004) · Current Drug Delivery · doi:10.2174/1567201043334542 · Cited by 162
BARRIER MECHANISMS IN THE BRAIN, I. ADULT BRAIN
Saunders, N., Habgood, M., & Dziegielewska, K. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.02986.x · Cited by 161
McKay, J. C., Prato, F. S., & Thomas, A. W. (2007) · Bioelectromagnetics · doi:10.1002/bem.20284 · Cited by 158
KUO, Y., & SU, F. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.012 · Cited by 158
The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders
Taylor, E. M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241020-00001 · Cited by 153
Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., Qi, M., Toh, J., Xu, G., Prasad, P. N., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.093 · Cited by 152
Why is the global CNS pharmaceutical market so under-penetrated?
Pardridge, W. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02082-7 · Cited by 148
Graff, C. L., & Pollack, G. M. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489126 · Cited by 147
PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases
Calvo, P., Gouritin, B., Brigger, I., Lasmézas, C. I., Deslys, J., Williams, A., Andreux, J. P., Dormont, D., & Couvreur, P. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00450-2 · Cited by 147
Wang, C., Le-song, H., Hou, L., Jiang, L., Yan, Z.-T., Wang, Y.-L., & Chen, Z.-L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.011 · Cited by 146
Effects of single-walled carbon nanotubes on the polymerase chain reaction
Cui, D., Tian, F., Kong, Y., Titushikin, I., & Gao, H. (2003) · Nanotechnology · doi:10.1088/0957-4484/15/1/030 · Cited by 143
Self-citationChoi, J. J., Pernot, M., Brown, T. R., Small, S. A., & Konofagou, E. E. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/18/004 · Cited by 141 · cited 1×
“demonstrating deposition of gadolinium through ultrasound-induced blood-brain barrier (BBB) openings in the murine hippocampus [65].”
BackgroundSchröder, U., & Sabel, B. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01375-x · Cited by 141
Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 139
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
Grimm, J., Kirsch, D. G., Windsor, S. D., Kim, C. F. B., Santiago, P. M., Ntziachristos, V., Jacks, T., & Weissleder, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503920102 · Cited by 138
Self-citationDelivery of serotonin to the brain by monocytes following phagocytosis of liposomes
Afergan, E., Epstein-Barash, H., Dahan, R., Koroukhov, N., Rohekar, K., Danenberg, H. D., & Golomb, G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.017 · Cited by 136
Hybrid FMT–CT imaging of amyloid-β plaques in a murine Alzheimer's disease model
Hyde, D. E., DEKLEINE, R., MacLaurin, S. A., Miller, E. L., BROOKS, D., Krucker, T., & Ntziachristos, V. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.038 · Cited by 134
Self-citationMaratos-Flier, E., Kao, C. Y., Verdin, E. M., & King, G. L. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.4.1595 · Cited by 133
Negligible clearance of ultrafine particles retained in healthy and affected human lungs
Wiebert, P., Sanchez-Crespo, A., Seitz, J., Falk, R., Philipson, K., Kreyling, W. G., Möller, W., Sommerer, K., Larsson, S., & Svartengren, M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00103805 · Cited by 128
Self-citationShir, A., Ogris, M., Wagner, E., & Levitzki, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030006 · Cited by 124
Real-time MR imaging of adeno-associated viral vector delivery to the primate brain
Fiandaca, M. S., Varenika, V., Eberling, J., McKnight, T., Bringas, J., Pivirotto, P., Beyer, J., Hadaczek, P., Bowers, W., Park, J., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.11.012 · Cited by 122
Application of nanoparticles for the delivery of drugs to the brain
Kreuter, J. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.014 · Cited by 119
Tight Junction Regulation by Morphine and HIV-1 Tat Modulates Blood–Brain Barrier Permeability
Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Fernandez, S. F., Chawda, R., Shanahan, T., & Schwartz, S. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9208-1 · Cited by 117
Noninvasive label-free imaging of microhemodynamics by optical-resolution photoacoustic microscopy
Hu, S., Maslov, K., & Wang, L. V. (2009) · Optics Express · doi:10.1364/oe.17.007688 · Cited by 117
Wang, Y., Wu, Y.-T., Huang, H.-Y., Lin, H.-I., Lo, L., Tzeng, S., & Yang, C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.050 · Cited by 114
Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons
Townsend, S. A., Evrony, G. D., Gu, F., Schulz, M. P., Brown, R. H., & Langer, R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.011 · Cited by 111
Leergaard, T. B., Bjaalie, J. G., Devor, A., Wald, L. L., & Dale, A. M. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.07.009 · Cited by 109
Stoeger, T., Takenaka, S., Frankenberger, B., Ritter, B., Karg, E., Maier, K., Schulz, H., & Schmid, O. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.11370 · Cited by 109
Self-citationIntracellular Delivery of Nanoparticles Via the HIV-1 Tat Peptide
Berry, C. (2008) · Nanomedicine · doi:10.2217/17435889.3.3.357 · Cited by 105
Kusuhara, H., Suzuki, H., Naito, M., TSURUO, T., & Sugiyama, Y. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37528-7 · Cited by 104
Kratzer, I., Wernig, K., Panzenboeck, U., Bernhart, E., Reicher, H., Wronski, R., Windisch, M., Hammer, A., Malle, E., Zimmer, A., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.020 · Cited by 104
In vivo imaging of Drosophila melanogaster pupae with mesoscopic fluorescence tomography
Vinegoni, C., Pitsouli, C., Razansky, D., Perrimon, N., & Ntziachristos, V. (2007) · Nature Methods · doi:10.1038/nmeth1149 · Cited by 103
Self-citationA Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
Karkan, D., Pfeifer, C., Vitalis, T. Z., Arthur, G., Ujiie, M., Chen, Q., Tsai, S., Koliatis, G., Gabathuler, R., & Jefferies, W. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002469 · Cited by 102
Efficacy of Oral Dalargin-loaded Nanoparticle Delivery across the Blood–Brain Barrier
Schröeder, U., Sommerfeld, P., & Sabel, B. A. (1998) · Peptides · doi:10.1016/s0196-9781(97)00474-9 · Cited by 101
Beyerle, A., Merkel, O. M., Stoeger, T., & Kissel, T. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.10.001 · Cited by 100
Self-citationEvaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
Pardridge, W. M., Triguero, D., Buciak, J., & Yang, J. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23180-9 · Cited by 96
Nanohybrid scratch resistant coatings for teeth and bone viscoelasticity manifested in tribology
de la Isla, A., Brostow, W., Bujard, B., Estévez, M., Rodríguez, R., Vargas, S., & Castaño, V. M. (2003) · Materials Research Innovations · doi:10.1080/14328917.2003.11784770 · Cited by 94
The Blood-Brain Barrier and Drug Delivery to the CNS
(2000) · CRC Press eBooks · doi:10.1201/9780824741990 · Cited by 90
Sensitivity of molecular target detection by multispectral optoacoustic tomography (MSOT)
Razansky, D., Baeten, J., & Ntziachristos, V. (2009) · Medical Physics · doi:10.1118/1.3077120 · Cited by 90
Self-citationZeuthen, T. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018871 · Cited by 90
Effects of Antisense-Myc-Conjugated Single-Walled Carbon Nanotubes on HL-60Cells
Cui, D., Tian, F., Coyer, S. R., Wang, J., Pan, B., Gao, F., He, R., & Zhang, Y. (2007) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2007.348 · Cited by 89
Self-citationAnnunziata, P. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1159-0 · Cited by 89
Tabernero, A., Velasco, A., Granda, B., Lavado, E. M., & Medina, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108760200 · Cited by 79
McCann, C. M., Waterman, P. R., Figueiredo, J., Aïkawa, E., Weissleder, R., & Chen, J. W. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.022 · Cited by 79
Liu, H., Liu, X.-F., Yao, J.-L., Wang, C., Yu, Y., & Wang, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106484 · Cited by 71
Deguchi, Y., Okutsu, H., Okura, T., Yamada, S., Kimura, R., Yuge, T., Furukawa, A., Morimoto, K., Tachikawa, M., Ohtsuki, S., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01129.x · Cited by 69
An, J., Zhang, C., Polavarapu, R., Zhang, X., Zhang, X., & Yepes, M. (2008) · Blood · doi:10.1182/blood-2008-02-141630 · Cited by 68
Deguchi, T., Isozaki, K., Kouno, Y., Terasaki, T., & Otagiri, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03550.x · Cited by 67
Role of ABC Transporters in the Chemoresistance of Human Gliomas
Decleves, X., Amiel, A., Delattre, J.-Y., & Scherrmann, J.-M. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723930 · Cited by 65
Suci, P. A., Berglund, D. L., Liepold, L. O., Brumfield, S. K., Pitts, B., Davison, W., Oltrogge, L. M., Hoyt, K. O., Codd, S. L., Stewart, P. S., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.02.006 · Cited by 64
Czerniawska, A. (1970) · Acta Oto-Laryngologica · doi:10.3109/00016487009181859 · Cited by 59
Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.
Gonzalez-Alegre, P. (2007) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2007.01.003 · Cited by 53
In Vivo Distribution of Liposome‐Encapsulated Hemoglobin Determined by Positron Emission Tomography
Urakami, T., Kawaguchi, A. T., Akai, S., Hatanaka, K., Koide, H., Shimizu, K., Asai, T., Fukumoto, D., Harada, N., Tsukada, H., et al. (2009) · Artificial Organs · doi:10.1111/j.1525-1594.2008.00702.x · Cited by 52
Ay, İ., Francis, J. W., & Brown, R. H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.121 · Cited by 51
Effects of lipopolysaccharide on leptin transport across the blood–brain barrier
Nonaka, N., Hileman, S. M., Shioda, S., Vo, T. Q., & Banks, W. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.066 · Cited by 50
Deltorphin transport across the blood–brain barrier
Fiori, A., Cardelli, P., Negri, L., Savi, M. R., Ström, R., & Erspamer, V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9469 · Cited by 49
Chien, A. J., Illi, J., Ko, A. H., Korn, W. M., Fong, L. H., Chen, L.-M., Kashani–Sabet, M., Ryan, C. J., Rosenberg, J. E., Dubey, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0522 · Cited by 49
Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats
Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Kreuter, J., & Gelperina, S. E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.01.020 · Cited by 47
Adsorptive-mediated endocytosis of a basic peptide in enterocyte-like Caco-2 cells
Sai, Y., Kajita, M., Tamai, I., Wakama, J., Wakamiya, T., & Tsuji, A. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.3.g514 · Cited by 46
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma
Plotkin, M., Gneveckow, U., Maier-Hauff, K., Amthauer, H., Feussner, A., Denecke, T., Gutberlet, M., Jordan, A., Felix, R., & Wust, P. (2006) · International Journal of Hyperthermia · doi:10.1080/02656730600734128 · Cited by 45
Khan, N. A., Cello, F. D., Stins, M. F., & Kim, K. S. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701286531 · Cited by 42
Effects of Pluronic P85 on GLUT1 and MCT1 Transporters in the Blood-Brain Barrier
Batrakova, E. V., Zhang, Y., Li, Y., Li, S., Vinogradov, S. V., Persidsky, Y., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048189.79606.6e · Cited by 41
Pertussis toxin induces angiogenesis in brain microvascular endothelial cells
Lu, C., Pelech, S., Zhang, H., Bond, J., Spach, K., Noubade, R., Blankenhorn, E. P., & Teuscher, C. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21716 · Cited by 41
Narushima, I., Kita, T., Kubo, K., Yonetani, Y., Momochi, C., Yoshikawa, I., Ohno, N., & Nakashima, T. (2003) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2003.920104.x · Cited by 40
Oberd√∂rster, G., M√∂ller, W., Semmler‐Behnke, M., & Kreyling, W. G. (2006) · Informa Healthcare eBooks · doi:10.1201/9781420003147.ch3 · Cited by 40
Self-citationBanks, W. A., Kastin, A. J., & Ehrensing, C. A. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350611 · Cited by 36
Alonzi, R., & Hoskin, P. (2006) · Clinical Oncology · doi:10.1016/j.clon.2006.06.002 · Cited by 34
Nanoparticles in Medicine and Environment: Inhalation and Health Effects
Marijnissen, J. C. M., & Gradoń, L. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.br01 · Cited by 34
Cited by
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 565
Nanotechnological advances for the delivery of cns therapeutics.
Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488
Metadata
- Authors
- Bhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J. M., Grazú, V., Borm, P., Estrada, G., Ntziachristos, V., & Razansky, D.
- Venue
- Particle and Fibre Toxicology
- Published
- 2010-03-03
- Volume
- 7
- Issue
- 1
- Pages
- 3-3
- ISSN
- 1743-8977 (ISSN-L)
- OpenAlex
- W2140181820
- Cited by
- 495
- References
- 212
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.